Plain-English translation of NCT02393703 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This study is investigating tiny particles called exosomes that float in your blood and carry important signals between cells. Researchers want to compare these particles in people with pancreatic cancer versus people with non-cancerous pancreatic conditions to understand whether exosomes might help predict how the disease will progress. By studying these natural messenger systems, scientists hope to develop new ways to detect and monitor pancreatic cancer in the future.
Right now, doctors don't have clear standard measurements for what normal exosome activity looks like, making it hard to use these particles as early warning signs for cancer. This study aims to create a baseline of normal values and explore whether changes in exosome activity could help predict which patients are at higher risk of cancer recurrence.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will collect blood and tissue samples either before your pancreatic surgery or during the surgery itself, depending on which part of the study you're in. Some participants may also be followed to see if their samples show connections to cancer recurrence. The study involves no extra hospital visits beyond your already-planned surgery, though the research team will analyze your samples over time to look for patterns related to cancer outcomes.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States